Sequence Similarity Clusters for the Entities in PDB 4HWE

Entity #1 | Chains: H
Fab heavy chain protein, length: 227 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 48190
95 % 1 2 40029 Flexibility: Low
Max RMSD: 0.7, Avg RMSD: 0.7
PDBFlex
90 % 23 41 1009
70 % 1036 2655 2
50 % 2144 5473 1
40 % 2467 6175 1
30 % 2997 7653 1
Entity #2 | Chains: L
Fab light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 42733
95 % 35 103 220 Flexibility: Low
Max RMSD: 6.2, Avg RMSD: 1.8
PDBFlex
90 % 330 844 2
70 % 1044 2696 1
50 % 2145 5473 1
40 % 2468 6175 1
30 % 2998 7653 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
21 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
22 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
23 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
24 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
25 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
26 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
27 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
28 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
29 6MEE 2 B, D antibody HEPC74 Light Chain 9606
30 6BJZ 1 H 5c8 Fab Heavy chain 9606
31 6BJZ 2 L 5c8 Fab Light chain 9606
32 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
33 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
34 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
35 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
36 4XCF 1 L 4E10 Fab light chain 9606
37 4XCF 2 H 4E10 Fab heavy chain 9606
38 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
39 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
40 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
41 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
42 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
43 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
44 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
45 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
46 5X08 1 H Fab 4E10 Heavy chain 9606
47 5X08 2 L Fab 4E10 Light chain 9606
48 6MEG 1 H antibody HEPC46 Heavy Chain 9606
49 6MEG 2 L antibody HEPC46 Light Chain 9606
50 4XAW 1 L 4E10 Fab light chain 9606
51 4XAW 2 H 4E10 Fab heavy chain 9606
52 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
53 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
54 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
55 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
56 5UCB 1 H Fab Heavy Chain 9606
57 5UCB 2 L Fab Light Chain 9606
58 2VXV 1 H HUMAN IGG ABT-325 9606
59 2VXV 2 L HUMAN IGG ABT-325 9606
60 4GXV 1 H, I Antibody 1F1, heavy chain 9606
61 4GXV 2 L, M Antibody 1F1, light chain 9606
62 2VXT 1 H MURINE IGG 125-2H 10090
63 2VXT 3 L MURINE IGG 125-2H 10090
64 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
65 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
66 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
67 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
68 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
69 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
70 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
71 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
72 5W24 1 L 5C4 Fab Light Chain 10090
73 5W24 2 H 5C4 Fab Heavy Chain 10090
74 4HPY 1 H CH59 Fab heavy chain 9606
75 4HPY 2 L CH59 Fab light chain 9606
76 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
77 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
78 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
79 4JG1 1 L Fab light chain 9606
80 4JG1 2 H Fab heavy chain 9606
81 6E65 1 L TB31F Fab light chain 9606
82 6E65 2 H TB31F Fab heavy chain 9606
83 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
84 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
85 5VF2 1 A scFv 2D10 10090
86 5I8C 1 A VRC34.01 Fab heavy chain 9606
87 5I8C 2 B VRC34.01 Fab light chain 9606
88 4O5L 1 L Fab F045-092 light chain 9606
89 4O5L 2 H Fab F045-092 heavy chain 9606
90 5MYX 1 A, C Fab c#24 light chain 10090
91 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
92 3IFL 1 L 12A11 FAB antibody light chain 10090
93 3IFL 2 H 12A11 FAB antibody heavy chain 10090
94 5WK2 1 L M116 LIGHT CHAIN 9606
95 5WK2 2 H M116 HEAVY CHAIN FD 9606
96 3PP4 1 H GA101 Fab heavy chain 10090
97 3PP4 2 L GA101 Fab light chain 10090
98 3KDM 1 A, L Immunoglobulin light chain 9606
99 3KDM 2 B, H Immunoglobulin heavy chain 9606
100 5NIV 1 A Light chain of 5D3 Fab 10090
101 5NIV 2 B Heavy chain of 5D3 Fab 10090
102 5N4J 1 L LIGHT CHAIN 9606
103 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
104 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
105 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
106 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
107 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
108 5X4G 1 A 6H8 Fab heavy chain 10090
109 5X4G 2 B 6H8 Fab light chain 10090
110 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
111 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
112 4PTU 1 A Antibody pn132p2C05, light chain 9606
113 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
114 4TPR 1 L If kappa light chain 10090
115 4TPR 2 H Fab heavy chain 10090
116 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
117 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
118 3IFN 1 H 12A11 FAB antibody heavy chain 10090
119 3IFN 2 L 12A11 FAB antibody light chain 10090
120 5U3P 1 H DH511.4 Fab Heavy Chain 9606
121 5U3P 2 L DH511.4 Fab Light Chain 9606
122 6BLA 1 H AMM01 Fab Heavy chain 9606
123 6BLA 2 L AMM01 Fab Light chain 9606
124 4TOY 1 H 35O22 Fab Heavy chain 9606
125 4TOY 2 L 35O22 Fab Light chain 9606
126 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
127 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
128 3NPS 2 B S4 FAB HEAVY CHAIN 9606
129 3NPS 3 C S4 FAB LIGHT CHAIN 9606
130 5I4F 1 A scFv 2D10 10090
131 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
132 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
133 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
134 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
135 5WN9 1 H scFv 2D10 9606
136 4XC3 1 L 4E10 Fab light chain 9606
137 4XC3 2 H 4E10 Fab heavy chain 9606
138 4M5Y 1 H, I Fab 5J8 heavy chain 9606
139 4M5Y 2 L, M Fab 5J8 light chain 9606
140 4TQE 1 L If kappa light chain 10090
141 4TQE 2 H Fab heavy chain 10090
142 5YY4 1 A scFv 4B08 10090
143 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
144 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
145 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
146 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
147 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
148 5VSI 2 L CH1/Ckappa Fab light chain 9606
149 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
150 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
151 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
152 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
153 5JXA 1 H VRC03 Heavy chain 9606
154 5JXA 2 L VRC03 Light chain 9606
155 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
156 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
157 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
158 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
159 3NTC 1 L Fab light chain 10090
160 3NTC 2 H Fab heavy chain 10090
161 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
162 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
163 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
164 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
165 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
166 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
167 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
168 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
169 6BE3 1 H Fab (F598) Heavy Chain 9606
170 6BE3 2 L Fab (F598) Light Chain 9606
171 4NWU 1 H APE1551 Ab Fab heavy chain 9606
172 4NWU 2 L APE1551 Ab Fab light chain 9606
173 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
174 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
175 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
176 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
177 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
178 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
179 5EWI 1 H VRC38.01 Heavy Chain 9606
180 5EWI 2 L VRC38.01 Light Chain 9606
181 5E2W 1 L AT8 LIGHT CHAIN 10090
182 5E2W 2 H AT8 HEAVY CHAIN 10090
183 5MYK 1 A Fab c#17 light chain 10090
184 5MYK 2 B Fab c#17 heavy chain 10090
185 4NZR 1 H PGT135 heavy chain Fab 9606
186 4NZR 2 L PGT135 light chain Fab 9606
187 5MYO 1 A, C Fab c#6 light chain 10090
188 5MYO 2 B, D Fab c#6 heavy chain 10090
189 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
190 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
191 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
192 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
193 5UEL 1 H 354NC102 Fab Heavy Chain 9606
194 5UEL 2 L 354NC102 Fab Light Chain 9606
195 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
196 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
197 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
198 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
199 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
200 5E2V 1 L AT8 LIGHT CHAIN 10090
201 5E2V 2 H AT8 HEAVY CHAIN 10090
202 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
203 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
204 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
205 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
206 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
207 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
208 5JUE 1 L light chain of UIC2 Fab 10090
209 5JUE 2 H heavy chain of UIC2 Fab 10090
210 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
211 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
212 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
213 5JR1 1 H 10E8 heavy chain 9606
214 5JR1 2 L 10E8 mature light chain 9606
215 6CA7 1 L PCT64_13C light chain 9606
216 6CA7 2 H PCT64_13C heavy chain 9606
217 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
218 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
219 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
220 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
221 5OB5 2 H fAb Heavy chain 9606
222 5OB5 3 L fAb Light chain 9606
223 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
224 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
225 5I66 1 A 8B6 antibody, heavy chain 10090
226 5I66 2 B 8B6 antibody, light chain 10090
227 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
228 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
229 6BZY 1 H 22D11 Heavy Chain 10090
230 6BZY 2 L 22D11 Light Chain 10090
231 3QQ9 1 C, L 101F LIGHT CHAIN 10090
232 3QQ9 2 D, H 101F HEAVY CHAIN 10090
233 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
234 5TKK 3 L mouse antibody vFP5.01 light chain 10090
235 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
236 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
237 5W6C 1 H UCA Fab heavy chain 9606
238 5W6C 2 L UCA Fab light chain 9606
239 5I1K 1 L FAB LIGHT CHAIN 9606
240 5I1K 2 H FAB HEAVY CHAIN 9606
241 3OZ9 1 L Fab NC-1 kappa light chain 10090
242 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
243 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
244 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
245 5V7U 1 L CBTAU-22.1 Fab light chain 9606
246 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
247 5UEA 1 A, H Fab Heavy Chain 9606
248 5UEA 3 B, L Fab Light Chain 9606
249 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
250 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
251 3G5Y 1 A 175 light chain 10090
252 3G5Y 2 B 175 heavy chain 10090
253 5NMV 1 L Fab light chain 10088
254 5NMV 2 H Fab heavy chain 10088
255 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
256 4N8C 2 L, M Light chain of monoclonal antibody 10090
257 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
258 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
259 4HGW 1 A Antibody Fab fragment, light chain 10090
260 4HGW 2 B Antibody Fab fragment, heavy chain 10090
261 1NLB 1 L antibody 19D9D6 light chain 10090
262 1NLB 2 H antibody 19D9D6 heavy chain 10090
263 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
264 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
265 3VFG 1 L 3F8 Light Chain 10090
266 3VFG 2 H 3F8 Heavy Chain 10090
267 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
268 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
269 3QRG 1 L Fab light chain 9606
270 3QRG 2 H Fab heavy chain Fd fragment 9606
271 5M6A 1 A, B, C, D Bence-Jones light chain 9606
272 4LLY 2 B, D light chain Clambda 9606
273 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
274 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
275 5EZI 1 H Fab c12 heavy chain 9606
276 5EZI 2 L Fab c12 Light chain 9606
277 4K23 1 H anti-uPAR antibody, heavy chain 10090
278 4K23 2 L anti-uPAR antibody, light chain 10090
279 3NCJ 1 L Fab15 Mut8 light chain 9606
280 3NCJ 2 H Fab15 Mut8 heavy chain 9606
281 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
282 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
283 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
284 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
285 5W05 1 L M59 FAB LIGHT CHAIN 10090
286 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
287 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
288 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
289 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
290 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
291 4M61 1 A, C Fab A52 light chain 10090
292 4M61 2 B, D Fab A52 heavy chain 10090
293 5YE3 1 B 2A7D9 VH CH1 chain 10090
294 5YE3 2 A 2A7D9 L chain 10090
295 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
296 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
297 1UM5 1 L Antibody 21H3 L chain 10090
298 1UM5 2 H Antibody 21H3 H chain 10090
299 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
300 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
301 4NWT 1 L APE1531 Ab Fab light chain 9606
302 4NWT 2 H APE1531 Ab Fab heavy chain 9606
303 3WHX 1 A mAb Fab H fragment 10090
304 3WHX 2 B mAb Fab L fragment 10090
305 3NA9 1 L Fab15 light chain 9606
306 3NA9 2 H Fab15 heavy chain 9606
307 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
308 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
309 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
310 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
311 4LRI 1 A, B MSL-109 Light Chain 9606
312 4LRI 2 C, P MSL-109 Heavy Chain 9606
313 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
314 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
315 4JN2 1 A, L anti dabigatran Fab 10090
316 4JN2 2 B, H anti dabigatran Fab 10090
317 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
318 4XBE 2 H 4E10 Fab heavy chain 9606
319 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
320 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
321 6BE2 1 H Fab (F598) Heavy Chain 9606
322 6BE2 2 L Fab (F598) Light Chain 9606
323 4JFZ 1 L Fab light chain 9606
324 4JFZ 2 H Fab heavy chain 9606
325 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
326 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
327 3WIF 1 A mAb Fab H fragment 10090
328 3WIF 2 B mAb Fab L fragment 10090
329 5U6A 1 A Light Chain 9606
330 5U6A 2 B Heavy Chain 9606
331 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
332 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
333 3MBX 1 L X836 LIGHT CHAIN 10090
334 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
335 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
336 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
337 6APC 1 H Epididymis luminal protein 214 9606
338 6APC 2 L IGL@ protein 9606
339 4HHA 1 A Fab KE5 Fab fragment KE5 9606
340 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
341 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
342 4RGO 2 H 14G8 heavy chain Fab 10090
343 4RGO 3 L 14G8 light chain Fab 10090
344 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
345 5GRY 1 A, G diabody 9606
346 5UEK 2 H Fab 12E Heavy Chain 9606
347 5UEK 3 L Fab 12E Light Chain 9606
348 3NAA 1 L Fab15 Mut5 light chain 9606
349 3NAA 2 H Fab15 Mut5 heavy chain 9606
350 1Q0X 1 L Fab 9B1, light chain 10090
351 1Q0X 2 H Fab 9B1, heavy chain 10090
352 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
353 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
354 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
355 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
356 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
357 5IK3 2 B, D 1E03 Fab fragment light chain 9606
358 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
359 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
360 5XLI 1 a, b FabL 10090
361 5XLI 2 c, d FabH 10090
362 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
363 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
364 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
365 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
366 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
367 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
368 4WUK 1 H CH65 heavy chain 9606
369 4WUK 2 L CH65 light chain 9606
370 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
371 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
372 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
373 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
374 5JOP 1 D, L Fab 14.22 light chain 10090
375 5JOP 2 E, H Fab14.22 heavy chain 10090
376 4HPO 1 H CH58 Fab heavy chain 9606
377 4HPO 2 L CH58 Fab light chain 9606
378 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
379 5UKN 2 L DH522UCA Fab fragment light chain 9544
380 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
381 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
382 5IT2 1 H heavy chain 9606
383 5IT2 2 L light chain 9606
384 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
385 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
386 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
387 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
388 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
389 5MO3 3 L Fab of monoclonal antibody, light chain 10090
390 5GZ0 1 A, C FM329 light chain 1383439
391 5GZ0 2 B, D FM329 heavy chain 1383439
392 6DW2 1 A 6078 Fab light chain 9606
393 6DW2 2 B 6078 Fab heavy chain 9606
394 6BQB 1 L MGG4 Fab light chain 9606
395 6BQB 2 H MGG4 Fab heavy chain 9606
396 4PUB 1 H DX-2930 HEAVY CHAIN 9606
397 4PUB 2 L DX-2930 LIGHT CHAIN 9606
398 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
399 6B14 2 L Light chain of Fab BL3-6S97N 10090
400 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
401 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
402 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
403 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
404 5GS3 1 A, H diabody protein 9606
405 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
406 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
407 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
408 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
409 5VKD 2 H Fab Heavy Chain 9606
410 5VKD 3 L Fab light chain 9606
411 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
412 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
413 5XHG 1 A, C polypeptide(L) 10090
414 5XHG 2 B, D polypeptide(H) 10090
415 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
416 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
417 3UYR 1 H antibody Fab heavy chain 10090
418 3UYR 2 L antibody Fab light chain 10090
419 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
420 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
421 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
422 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
423 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
424 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
425 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
426 3OAZ 2 K, L Fab 2G12, light chain 9606
427 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
428 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
429 1ZAN 1 L Fab AD11 Light Chain 10116
430 1ZAN 2 H Fab AD11 Heavy Chain 10116
431 6CJK 1 A, C Immunoglobulin Fab light chain 9986
432 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
433 4N0Y 1 H IGH526 Heavy Chain 9606
434 4N0Y 2 L IGH526 Light Chain 9606
435 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
436 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
437 5MTH 1 A, H antibody Fab heavy chain 10090
438 5MTH 2 B, L antibody Fab light chain 10090
439 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
440 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
441 1RZF 1 L Fab E51 light chain 9606
442 1RZF 2 H Fab E51 heavy chain 9606
443 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
444 4KTE 2 L GE148 Light Chain Fab 9544
445 5I8O 1 H HMM5 antibody heavy chain 9606
446 5I8O 2 L HMM5 antibody light chain 9606
447 4JG0 1 L Fab light chain 9606
448 4JG0 2 H Fab heavy chain 9606
449 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
450 4YGV 2 B, L aDabi-Fab2a light chain 9606
451 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
452 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
453 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
454 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
455 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
456 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
457 3EO0 1 A, C GC-1008 Fab Light Chain 10090
458 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
459 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
460 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
461 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
462 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
463 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
464 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
465 4FQI 3 H antibody CR9114 heavy chain Fab 9606
466 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
467 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
468 4JHA 2 L D25 light chain 9606
469 6B9Z 1 A Trastuzumab Fab light chain 10090
470 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
471 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
472 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
473 4PTT 1 A Antibody pn132p2C05, light chain 9606
474 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
475 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
476 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
477 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
478 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
479 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
480 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
481 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
482 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
483 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
484 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
485 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
486 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
487 4DGV 1 H HCV1 Heavy Chain Fab 9606
488 4DGV 2 L HCV1 Light Chain 9606
489 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
490 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
491 5TH2 1 A, C cetuximab Fab, light chain 10090
492 5TH2 2 B, D cetuximab Fab, heavy chain 10090
493 5I8K 1 L HHH1 Fab Light chain 9606
494 5I8K 2 H HHH1 Fab Heavy chain 9606
495 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
496 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
497 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
498 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
499 1YNL 1 L Ig gamma light chain 10090
500 1YNL 2 H Ig gamma heavy chain 10090
501 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
502 5EPM 2 B, F Antibody Fab fragment light chain 10090
503 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
504 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
505 3UMT 1 A scFv heavy chain and light chain 10090
506 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
507 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
508 4NUJ 1 A PGT152 light chain 9606
509 4NUJ 2 B PGT152 heavy chain 9606
510 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
511 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
512 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
513 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
514 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
515 3U2S 2 B, L PG9 light chain 9606
516 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
517 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
518 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
519 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
520 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
521 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
522 4NUG 1 L PGT151 light chain 9606
523 4NUG 2 H PGT151 heavy chain 9606
524 3IU4 1 H chP3 Fab heavy chain 10090
525 3IU4 2 L chP3 Fab light chain 10090
526 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
527 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
528 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
529 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
530 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
531 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
532 1P7K 1 A, L antibody light chain FAB 10090
533 1P7K 2 B, H antibody heavy chain FAB 10090
534 3RVV 2 C 4C1 - light chain 10090
535 3RVV 3 D 4C1 - heavy chain 10090
536 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
537 3P0Y 2 H Fab DL11 heavy chain 9606
538 3P0Y 3 L Fab DL11 light chain 9606
539 4NPY 1 A, L germline PGT121 light chain Fab 9606
540 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
541 6ANA 2 H LL2 Fab Heavy Chain 10090
542 6ANA 3 L LL2 Fab Light Chain 10090
543 5IBU 1 B, L 6652 Light Chain 9606
544 5IBU 2 G, H 6652 Heavy Chain 9606
545 5VPL 2 C 4C1 - LIGHT CHAIN 10090
546 5VPL 3 D 4C1 - HEAVY CHAIN 10090
547 6AOD 1 A FXIa Antibody FAB Light Chain 9606
548 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
549 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
550 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
551 2YPV 2 H FAB 12C1 10090
552 2YPV 3 L FAB 12C1 10090
553 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
554 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
555 4JY5 1 L PGT122 light chain Fab 9606
556 4JY5 2 H PGT122 heavy chain Fab 9606
557 6ELE 1 A, H fAB heavy chain 9606
558 6ELE 2 B, L fAB light chain 9606
559 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
560 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
561 6B5R 1 H CIS42 Fab Heavy chain 9606
562 6B5R 2 L CIS42 Fab Light chain 9606
563 3NAC 1 L Fab15 Mut7 light chain 9606
564 3NAC 2 H Fab15 Mut7 heavy chain 9606
565 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
566 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
567 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
568 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
569 1Q72 1 L Fab M82G2, Light chain 10090
570 1Q72 2 H Fab M82G2, Heavy chain 10090
571 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
572 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
573 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
574 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
575 4YHO 1 H aDabi-Fab3 heavy chain 9606
576 4YHO 2 L aDabi-Fab3 light chain 9606
577 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
578 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
579 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
580 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
581 4DGY 1 H HCV1 Heavy Chain Fab 9606
582 4DGY 2 L HCV1 Light Chain 9606
583 5EN2 1 A GD01 heavy chain 10090
584 5EN2 2 B GD01 light chain 10090
585 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
586 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
587 3MXW 2 L 5E1 light chain 9606
588 3MXW 3 H 5E1 heavy chain 9606
589 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
590 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
591 3EO9 1 L Efalizumab Fab fragment, light chain 9606
592 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
593 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
594 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
595 6N35 1 K, L Fab 2G12 light chain 9606
596 6N35 2 H, M Fab 2G12 heavy chain 9606
597 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
598 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
599 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
600 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
601 5WUV 1 L light chain 9606
602 5WUV 2 H heavy chain 9606
603 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
604 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
605 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
606 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
607 4JM4 1 H PGT 135 Heavy Chain Fab 9606
608 4JM4 2 L PGT 135 Light Chain Fab 9606
609 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
610 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
611 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
612 5YE4 2 B, D 1A9D7 L chain 10090
613 6B0G 1 C 1245 Antibody, Light Chain 9606
614 6B0G 2 D 1245 Antibody, Heavy Chain 9606
615 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
616 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
617 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
618 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
619 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
620 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
621 6D0X 1 A 2140 Antibody, heavy chain 9606
622 6D0X 2 B 1210 Antibody, light chain 9606
623 6BE4 1 H Fab (F598) Heavy Chain 9606
624 6BE4 2 L Fab(F598) Light Chain 9606
625 5TPP 1 L DH270.5 Fab heavy chain 9606
626 5TPP 2 H DH270.5 Fab light chain 9606
627 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
628 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
629 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
630 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
631 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
632 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
633 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
634 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
635 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
636 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
637 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
638 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
639 5TL5 1 L M2177 LIGHT CHAIN 10090
640 5TL5 2 H M2177 HEAVY CHAIN 10090
641 2FX7 1 L Fab 4E10 Light Chain 9606
642 2FX7 2 H Fab 4E10 Heavy Chain 9606
643 5Y9K 1 L belimumab light chain 9606
644 5Y9K 2 H belimumab heavy chain 9606
645 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
646 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
647 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
648 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
649 3WFH 1 A mAb Fab H fragment 10090
650 3WFH 2 B mAb Fab L fragment 10090
651 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
652 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
653 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
654 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
655 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
656 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
657 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
658 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
659 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
660 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
661 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
662 5HI4 3 D, L CAT-2000 FAB light chain 9606
663 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
664 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
665 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
666 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
667 3RVW 2 C 4C1 - light chain 10090
668 3RVW 3 D 4C1 - heavy chain 10090
669 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
670 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
671 5XKU 2 B HNIgGA6 light chain 9606
672 5XKU 3 C HNIgGA6 heavy chain 9606
673 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
674 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
675 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
676 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
677 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
678 5HI5 3 D, L CAT-2000 light chain 9606
679 5JO5 1 A, C, E, H 10E8 gHV 9606
680 5JO5 2 B, D, F, L 10E8 gLV 9606
681 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
682 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
683 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
684 5CCK 2 L Antibody 3BC315 Fab light chain 9606
685 5I76 1 A, C FM318_light_chain 1383439
686 5I76 2 B, D FM318_heavy_cahin 1383439
687 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
688 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
689 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
690 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
691 5I18 1 L FAB LIGHT CHAIN 9606
692 5I18 2 H FAB HEAVY CHAIN 9606
693 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
694 4JN1 2 L anti-dabigatran Fab1, light chain 10090
695 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
696 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
697 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
698 4G5Z 2 L canakinumab antibody fragment light chain 9606
699 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
700 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
701 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
702 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
703 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
704 2OK0 2 L Fab ED10 light chain 10090
705 2OK0 3 H Fab ED10 heavy chain 10090
706 3SOB 1 L antibody light chain 9606
707 3SOB 3 H antibody heavy chain 9606
708 6B5M 1 H CIS43 Fab Heavy chain 9606
709 6B5M 2 L CIS43 Fab Light chain 9606
710 5AWN 1 H Heavy chain of 3BC176 Fab 9606
711 5AWN 2 L Light chain of 3BC176 Fab 9606
712 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
713 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
714 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
715 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
716 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
717 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
718 5DR5 2 L AbD09097 Fab light chain 9606
719 2IH3 1 A FAB Heavy Chain 10090
720 2IH3 2 B FAB Light Chain 10090
721 4KQ3 1 L CNTO3186 light chain Fab 9606
722 4KQ3 2 H CNTO3186 heavy chain Fab 9606
723 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
724 6AQ7 3 L POM6 FAB light CHAIN 10090
725 4JFX 1 A, L Fab light chain 9606
726 4JFX 2 B, H Fab heavy chain 9606
727 3SGE 1 I, L Light Chain 10090
728 3SGE 2 H, J Heavy Chain 10090
729 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
730 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
731 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
732 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
733 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
734 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
735 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
736 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
737 5FHB 1 H Antibody 100 Fab heavy chain 9606
738 5FHB 2 L Antibody 100 Fab light chain 9606
739 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
740 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
741 1JGU 1 L Antibody Light Chain 10090
742 1JGU 2 H Antibody Heavy Chain 10090
743 4I77 1 H Lebrikizumab heavy chain Fab 9606
744 4I77 2 L Lebrikizumab light chain Fab 9606
745 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
746 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
747 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
748 4O4Y 2 H 2095-2 heavy chain 9986
749 5OBF 1 H fAb Heavy chain 10090
750 5OBF 2 L fAb Light chain 10090
751 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
752 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
753 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
754 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
755 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
756 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
757 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
758 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
759 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
760 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
761 5MHE 1 L Fab-fragment 10090
762 5MHE 2 H Fab-fragment 10090
763 5YFI 1 L Light chain of Fab fragment 10090
764 5YFI 2 H Heavy chain of Fab fragment 10090
765 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
766 4GLR 3 I, K anti-ptau light chain light chain 9031
767 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
768 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
769 4HJG 1 A Trastuzumab light chain 9606
770 4HJG 2 B Trastuzumab heavy chain 9606
771 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
772 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
773 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
774 5I30 1 L Fab PL-2 light chain 10090
775 5I30 2 H Fab PL-2 heavy chain 10090
776 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
777 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
778 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
779 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
780 3FN0 1 L Fab Z13e1 light chain 9606
781 3FN0 2 H Fab Z13e1 heavy chain 9606
782 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
783 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
784 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
785 4YHI 2 B, L aDabi-Fab2a light chain 9606
786 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
787 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
788 4OSU 1 H SM5-1 Fab Heavy Chain 9606
789 4OSU 2 L SM5-1 Fab Light Chain 9606
790 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
791 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
792 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
793 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
794 1T2Q 1 L Fab NNA7 Heavy Chain 10090
795 1T2Q 2 H Fab NNA7 Light Chain 10090
796 6ELJ 1 A, H fAB heavy chain 9606
797 6ELJ 2 B, L fAB light chain 9606
798 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
799 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
800 4MAU 1 L C2244 light chain SEE REMARK 999 10090
801 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
802 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
803 3LEX 2 B, L 11f10 Antibody Light Chain 10090
804 6B0W 1 L 1710 antibody, light chain 9606
805 6B0W 2 H 1710 antibody, heavy chain 9606
806 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
807 5VH4 2 B, L Infliximab Fab Light Chain 10090
808 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
809 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
810 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
811 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
812 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
813 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
814 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
815 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
816 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
817 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
818 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
819 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
820 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
821 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
822 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
823 3S96 1 A, C 3B5H10 FAB heavy chain 10090
824 3S96 2 B, D 3B5H10 FAB light chain 10090
825 4LKX 1 A Fab fragment heavy chain 9606
826 4LKX 2 B Fab fragment light chain 9606
827 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
828 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
829 3SE8 2 H Heavy chain of antibody VRC03 Antigen binding fragement of antibody heavy chain 9606
830 3SE8 3 L Light chain of antibody VRC03 antibody light chain 9606
831 5JW5 1 A, H MEDI8852 Heavy chain 9606
832 5JW5 2 B, L MEDI8852 Light chain 9606
833 5VH3 1 A, H Infliximab Fab Heavy Chain 10090
834 5VH3 2 B, L Infliximab Fab Light Chain 10090
835 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
836 6DCV 2 B, H heavy chain of CBTAU-27.1 Fab 9606
837 5HDQ 2 H Fab Heavy Chain 10090
838 5HDQ 3 L Fab Light Chain 10090
839 4FQ2 1 H Fab heavy chain 9606
840 4FQ2 2 L Fab light chain 9606
841 3RKD 2 C, L Monoclonal Antibody, Light Chain 10090
842 3RKD 3 D, H Monoclonal Antibody, Heavy Chain 10090
843 3L1O 1 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 H CHAIN 10090
844 3L1O 2 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 L CHAIN 10090
845 2A77 1 L Immunoglobulin Light Chain 10090
846 2A77 2 H Immunoglobulin Heavy Chain 10090
847 2FB4 1 L IGG1-LAMBDA KOL FAB (LIGHT CHAIN) 9606
848 2FB4 2 H IGG1-LAMBDA KOL FAB (HEAVY CHAIN) 9606
849 3GO1 1 L Fab 268-D, light chain 9606
850 3GO1 2 H Fab 268-D, heavy chain 9606
851 1F3D 1 J, L CATALYTIC ANTIBODY 4B2 LIGHT CHAIN - FAB FRAGMENT 10090
852 1F3D 2 H, K CATALYTIC ANTIBODY 4B2 HEAVY CHAIN - FAB FRAGMENT 10090
853 3QWO 1 B, L motavizumab light chain 10090
854 3QWO 2 A, H motavizumab heavy chain 10090
855 3CVI 1 H 25-D1.16 Heavy chain 10090
856 3CVI 2 L 25-D1.16 Light chain 10090
857 1PZ5 1 A Light chain of Fab (SYA/J6) 10090
858 1PZ5 2 B Heavy chain of Fab (SYA/J6) 10090
859 1LK3 2 L, M 9D7 Light Chain Fab fragment, Residues 1-210 10116
860 1LK3 3 H, I 9D7 Heavy Chain Fab fragment, Residues 1-219 10116
861 4IOI 1 A Trastuzumab light chain 9606
862 4IOI 2 B Trastuzumab heavy chain 9606
863 1N7M 1 H Germline Metal Chelatase Catalytic Antibody, chain H 10090
864 1N7M 2 L Germline Metal Chelatase Catalytic Antibody, chain L 10090
865 4OKV 1 A, C heavy chain of 8H7 mAb 10090
866 4OKV 2 B, D light chain of 8H7 mAb 10090
867 6GHG 1 A, H Fab heavy chain 9606
868 6GHG 2 B, L Fab light chain 9606
869 6B5S 1 H CIS42 Fab Heavy chain 9606
870 6B5S 2 L CIS42 Fab Light chain 9606
871 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
872 5K8A 2 B, F, H, V Heavy chain 10090
873 5WKZ 1 H Immunoglobulin heavy variable 1-69D,IgG H chain 9606
874 5WKZ 2 L Lambda-chain (AA -20 to 215) 9606
875 1JGV 1 L Antibody Light Chain 10090
876 1JGV 2 H Antibody Heavy Chain 10090
877 5VAG 2 B Light chain of antibody m826 9606
878 5VAG 3 C Heavy chain of antibody m826 9606
879 3MLX 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
880 3MLX 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
881 3I9G 1 H Sonepcizumab antibody Fab fragment, heavy chain Fab Fragment 10090
882 3I9G 2 L Sonepcizumab antibody Fab fragment, light chain Fab Fragment 10090
883 5GIR 1 A, H Heavy chain of Fab fragment 10090
884 5GIR 2 B, L Light chain of Fab fragment 10090
885 2ADF 2 H 82D6A3 IgG FAB 10090
886 2ADF 3 L 82D6A3 IgG FAB 10090
887 5I16 1 A, L FAB LIGHT CHAIN 9606
888 5I16 2 B, H FAB HEAVY CHAIN 9606
889 3O41 1 B, L Mouse monoclonal antibody 101F Fab light chain 10090
890 3O41 2 A, H Mouse monoclonal antibody 101F Fab heavy chain 10090
891 5F9O 2 H CH235.9 Heavy chain 9606
892 5F9O 3 L CH235.09 Light chain 9606
893 3Q6G 1 L, M Light chain of Fab of rhesus mAb 2.5B 9544
894 3Q6G 2 H, I Heavy chain of Fab of rhesus mAb 2.5B 9544
895 1UM4 1 L Antibody 21H3 L chain 10090
896 1UM4 2 H Antibody 21H3 H chain 10090
897 5VJQ 1 A, C, E, G HyHEL10 heavy chain Fab fragment carrying three mutations; I29F, S52T, Y53F DEL-I 10090 3.2.1.18 | Details
898 5VJQ 2 B, D, F, H HyHEL10 light chain Fab fragment 10090
899 4RBP 1 K, L Fab 2G12 light chain 9606
900 4RBP 2 H, M Fab 2G12 heavy chain 9606
901 3I75 1 A Antibody heavy chain 10090
902 3I75 2 B Antibody light chain 10090
903 4XVS 1 H VRC07_1995 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Heavy chain 9606
904 4XVS 2 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 Light chain 9606
905 7FAB 1 L IGG1-LAMBDA NEW FAB (LIGHT CHAIN) 9606
906 7FAB 2 H IGG1-LAMBDA NEW FAB (HEAVY CHAIN) 9606
907 4FQL 1 H monoclonal antibody CR8033 heavy chain Fab 9606
908 4FQL 2 L monoclonal antibody CR8033 light chain Fab 9606
909 1NGX 1 A, L Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
910 1NGX 2 B, H Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
911 1E6O 1 H IMMUNOGLOBULIN HEAVY CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') HEAVY CHAIN 1-219 10090
912 1E6O 2 L IMMUNOGLOBULIN LIGHT CHAIN OBTAINED BY PEPSIN CLEAVAGE (FAB') LIGHT CHAIN 1-210 10090
913 5GIS 1 H Heavy chain of Fab fragment 10090
914 5GIS 2 L Light chain of Fab fragment 10090
915 1JFQ 1 L ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY LIGHT CHAIN 10090
916 1JFQ 2 H ANTIGEN-BINDING FRAGMENT OF ANTI-PHENYLARSONATE ANTIBODY HEAVY CHAIN 10090
917 6B0S 1 H 1710 antibody, heavy chain 9606
918 6B0S 2 L 1710 antibody, light chain 9606
919 5FGC 2 B Anti-HCV E2 Fab HC33.8 light chain 9606
920 5FGC 3 E Anti-HCV E2 Fab HC33.8 heavy chain 9606
921 5GRX 1 G, H diabody protein 9606
922 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
923 6DCW 2 H Heavy chain of CBTAU27.1 Fab 9606
924 6DB6 1 H Human monoclonal anti-HIV-1 gp120 V3 antibody 311-11D Fab heavy chain 9606
925 6DB6 2 L Human monoclonal anti-HIV-1 gp120 V3 antibody 311-11D Fab light chain 9606
926 4H20 1 L Light chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
927 4H20 2 H Heavy chain of Fab Fragment from the anti-Ricin Monoclonal Antibody RAC18 10090
928 5GGQ 1 L nivolumab light chain 9606
929 5GGQ 2 H nivolumab heavy chain 9606
930 4RFE 1 A, C, E, H Fab heavy chain of ADCC-potent anti-HIV-1 antibody JR4 9544
931 4RFE 2 B, D, F, L Fab light chain of ADCC-potent anti-HIV-1 antibody JR4 9544
932 6B5N 1 H CIS43 Fab Heavy chain 9606
933 6B5N 2 L CIS43 Fab Light chain 9606
934 3OAY 1 K, L Fab 2G12, light chain 9606
935 3OAY 2 H, M Fab 2G12, heavy chain 9606
936 1CR9 1 L FAB ANTIBODY LIGHT CHAIN HEAVY CHAIN 10090
937 1CR9 2 H FAB ANTIBODY HEAVY CHAIN LIGHT CHAIN 10090
938 6AND 2 H Pinatuzumab Fab Heavy chain 9606
939 6AND